Sign In
Buy LQDA
$55.69
+0.580 (+1.05%)
At Close: Jun 03, 2026
Liquidia Receives Favorable Ruling in Inter Partes Review against United Therapeutics Patent
05:23pm, Friday, 08'th Oct 2021
MORRISVILLE, N.C., Oct. 08, 2021 (GLOBE NEWSWIRE) -- Liquidia Corporation (NASDAQ: LQDA) announced today that the U.S. Patent Trial and Appeal Board (PTAB) ruled in its favor in the Inter Partes Revie
Liquidia to Participate at H.C. Wainwright 23rd Annual Global Investment Conference
08:29am, Friday, 10'th Sep 2021
MORRISVILLE, N.C., Sept. 10, 2021 (GLOBE NEWSWIRE) -- Liquidia Corporation (NASDAQ: LQDA) announced today that Damian deGoa, Chief Executive Officer, will present at the H.C. Wainwright 23rd Annual Gl
FDA Completes On-site Pre-Approval Inspection of Liquidia's Morrisville, North Carolina Facility
04:15pm, Wednesday, 18'th Aug 2021
No Form 483 observations were issued during 5-day inspection No Form 483 observations were issued during 5-day inspection
Liquidia Shares Increase Over 18% Intraday: Why It Happened
02:34pm, Thursday, 12'th Aug 2021
The shares of Liquidia Corp (NASDAQ: LQDA) increased by over 18% during intraday trading. This is why it happened.
Liquidia Corporation's (LQDA) CEO Damian deGoa on Q2 2021 Results - Earnings Call Transcript
10:22am, Tuesday, 10'th Aug 2021
Liquidia Corporation's (LQDA) CEO Damian deGoa on Q2 2021 Results - Earnings Call Transcript
Liquidia: Q2 Earnings Insights
07:08am, Tuesday, 10'th Aug 2021
Shares of Liquidia (NASDAQ:LQDA) fell 0.8% in pre-market trading after the company reported Q2 results. Quarterly Results Earnings per share rose 73.47% year over year to ($0.13), which beat the estim
Liquidia Reports Second Quarter 2021 Financial Results and Provides Corporate Update
07:00am, Tuesday, 10'th Aug 2021
MORRISVILLE, N.C., Aug. 10, 2021 (GLOBE NEWSWIRE) -- Liquidia Corporation (NASDAQ: LQDA) (“Liquidia” or the “Company”) today reported financial results for the quarter ended June 30, 2021. The
Liquidia: Martine Rothblatt's United Therapeutics Is Tough To Beat
09:42am, Monday, 09'th Aug 2021
LQDA is trying to bring a Tyvaso competitor to the market that allegedly works better. United is doing all it can to stop that.
Liquidia Announces Generic Treprostinil Injection Now Also Available for Subcutaneous Route of Administration
04:05pm, Monday, 24'th May 2021
Sandoz Generic Treprostinil Injection now available for both routes of administration, subcutaneous and intravenous Sandoz Generic Treprostinil Injection now available for both routes of administratio
Liquidia Technologies, Inc. (LQDA) Reports Q1 Loss, Tops Revenue Estimates
12:55pm, Thursday, 13'th May 2021
Liquidia Technologies, Inc. (LQDA) delivered earnings and revenue surprises of -5.00% and 260.28%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the
Liquidia Technologies, Inc. (LQDA) CEO Damian deGoa on Q1 2021 Results - Earnings Call Transcript
12:08pm, Thursday, 13'th May 2021
Liquidia Technologies, Inc. (LQDA) CEO Damian deGoa on Q1 2021 Results - Earnings Call Transcript
MORRISVILLE, N.C., May 10, 2021 (GLOBE NEWSWIRE) -- Liquidia Corporation (NASDAQ: LQDA) announced today that on May 7, 2021, it resubmitted its New Drug Application (NDA) for LIQ861 for the treatment
Rising P/E: An Overlooked Way to Pick 5 Winning Stocks
06:46am, Thursday, 29'th Apr 2021
Want to try an out-of-the-box approach? Tap five stocks with increasing P/E ratios.
Liquidia Announces Generic Treprostinil Injection Will Be Available for Subcutaneous Route of Administration
07:00am, Tuesday, 30'th Mar 2021
RESEARCH TRIANGLE PARK, N.C., March 30, 2021 (GLOBE NEWSWIRE) -- Liquidia Corporation (NASDAQ: LQDA) (“Liquidia” or the “Company”) today announced that Treprostinil Injection, a generic form o
Liquidia Technologies, Inc. (LQDA) CEO Damian deGoa on Q4 2020 Results - Earnings Call Transcript
01:05pm, Tuesday, 23'rd Mar 2021
Liquidia Technologies, Inc. (LQDA) CEO Damian deGoa on Q4 2020 Results - Earnings Call Transcript
